Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse

Seminars in Cancer Biology

Volumn 11, Issue 3, 2001, Pages 227-238

  Chang, Sandy ^a,c   Khoo, Christine ^a,b   DePinho, Ronald A ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cancer; Carcinoma; Fusion bridge breakage translocation; Genomic instability; Mouse models; Non reciprocal translocations; p53; Telomerase; Telomere

Indexed keywords

NUCLEOPROTEIN; PROTEIN P53; TELOMERASE;

ANEUPLOIDY; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CYTOGENETICS; EUKARYOTE; GENE MUTATION; HUMAN; LYMPHOMA; NONHUMAN; REVIEW; SOFT TISSUE SARCOMA; SPECIES DIFFERENCE; TELOMERE; TUMOR SUPPRESSOR GENE;

EID: 0034937190     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2000.0374     Document Type: Article

References (117)

1. Endogenous and exogenous hormonal factors
2. Lack of reciprocal translocations in carcinomas
3. The age distribution of cancer and a multi-stage theory of carcinogensis
4. How many mutations are required for tumorigenesis? Implications from human cancer data
5. Mutator phenotype may be required for multistage carcinogenesis
6. The hallmarks of cancer
7. Genetic instabilities in human cancers
8. The DNA damage response: Putting checkpoints in perspective
9. Mutations of mitotic checkpoint genes in human cancers
10. Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by nmtation of p53
11. Deficiency of p55 accelerates mammary: Tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability
12. The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma
13. Cytogenetic comparisons of synchronous carcinomas and polyps in patients with colorectal cancer
14. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
15. Centrosome hyperamplification in hmnan cancer: Chromosome instability, induced by p53 mutation and/or Mdm2 overexpression
16. Abnormal centrosome amplification in the absence of p53
17. Genetic instability in animal tumorigenesis models
18. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
19. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
20. In search of the tumour-suppressor functions of BRCA1 and BRCA2
21. Molecular genetics of breast cancer progression
22. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations
23. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. The breast cancer linkage consortium
24. Association of BRCA1 with Rad51 in mitotic and meiotic cells
25. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells
26. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
27. BRCA1 mutations in primary breast and ovarian carcinomas
28. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours
29. Flipping the oncogene switch: Illumination of tumor maintenance and regression
30. Tumor spectrum analysis in p53-mutant mice
31. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
32. Li-Fraumeni syndrome - A molecular and clinical review
33. p53 and the Li-Fraumeni syndrome
34. Telomeres and their control
35. Structure and function of telomeres
36. Telomere length regulation
37. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
38. The remaking of chromosomes
39. The stability of broken ends of chromosomes in Zea mays
40. The RNA component of human telomerase
41. The catalytic subunit of yeast telomerase
42. Human telomerase contains evolutionarily conserved catalytic and structural subunits
43. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types
44. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
45. Telomerase catalytic subunit homologs from fission yeast and human
46. TLPI: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family
47. Telomere length predicts replicative capacity of human fibroblasts
48. Tel omere dynamics and genomic instability in human cancer
49. Telomeres shorten during ageing of human fibroblasts
50. Telomerase, cell immortality, and cancer
51. The serial cultivation of human diploid cell strains
52. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes
53. Time, telomeres and tumours: Is cellular senescence more than an anticancer mechanisms?
54. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1
55. A role for both RB and p53 in the regulation of human cellular senescence
56. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
57. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen
58. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen
59. The biology, of replicative senescence
60. Extension of life-span by introduction of telomerase into normal human cells
61. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
62. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization
63. Telomerase activity, is sufficient to allow transformed cells to escape from crisis
64. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
65. Specific association of human telomerase activity with immortal cells and cancer
66. A survey of telomerase activity in human cancer
67. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
68. Telomere structure and telomerase expression during mouse development and tumorigenesis
69. Hypervariable ultra-long telomeres in mice
70. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
71. Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats
72. Genetic control of telomerase and replicative senescence in human and rodent cells
73. Telomere lengthening and telomerase activation during human B cell differentiation
74. Telomerase activity in human germline and embryonic tissues and cells
75. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation
76. Expression of mouse telomerase catalytic subunit in embryos and adult tissues
77. Developmental and tissue-specific regulation of mouse telomerase and telomere length
78. Essential role of mouse telomerase in highly proliferative organs
79. Longevity, stress response, and cancer in aging telomerase-deficient mice
80. Chromosome alterations in cancer development and apoptosis
81. Critical telomere shortening regulated by the ataxia-telangiectasia gene acts as a DNA damage signal leading to activation of p53 protein and limited life-span of human diploid fibroblasts
82. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving only (ADP-ribose) polymerase
83. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2
84. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
85. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway
86. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
87. 2/3 cancer-prone mouse
88. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
89. Creation of human tumor cells with defined genetic elements
90. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
91. Block in anaphase chromosome separation caused by a telomerase template mutation
92. Multicolor spectral karyotyping of human chromosomes
93. Mnlticolour spectral karyotyping of mouse chromosomes
94. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin
95. p53 mutations in hmnan cancers
96. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
97. p53 gene status and expression of p53, mdm2, and p21Waf1/Cip1 proteins in colorectal cancer
98. Gene copy number analysis by fluorescence in situ hybridization and comparative genomic hybridization
99. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays
100. Genome-wide analysis of DNA copy-number changes using cDNA microarrays
101. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
102. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
103. Transcriptional activation by tetracyclines in mammalian cells
104. Mammalian telomere dynamics: Healing, fragmentation shortening and stabilization
105. Genome changes and gene expression in human solid minors
106. Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization
107. Comparative genomic hybridization of ductal carcinoma in situ of the breast - Evidence of multiple genetic pathways
108. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases
109. Telomerase activity in ductal carcinoma in situ of the breast
110. Chromosomal banding patterns in human large bowel adenomas
111. Karyotypic characterization of colorectal adenocarcinomas
112. Allelic imbalance and cytogenetic deletion of 1p in colorectal adenomas: A target region identified between DIS199 and DIS234
113. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer
114. Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis
115. Telomerase activation in colorectal carcinogenesis